nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—ACE—urine—hypothyroidism	0.0695	0.193	CbGeAlD
Rescinnamine—ACE—nerve—hypothyroidism	0.048	0.133	CbGeAlD
Rescinnamine—Angina pectoris—Liothyronine—hypothyroidism	0.0343	0.0599	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Liothyronine—hypothyroidism	0.031	0.0541	CcSEcCtD
Rescinnamine—Myocardial infarction—Liothyronine—hypothyroidism	0.0308	0.0538	CcSEcCtD
Rescinnamine—Abscess—Liotrix—hypothyroidism	0.0257	0.0448	CcSEcCtD
Rescinnamine—Tingling sensation—Liotrix—hypothyroidism	0.0253	0.0441	CcSEcCtD
Rescinnamine—Hypertension—Liothyronine—hypothyroidism	0.0212	0.037	CcSEcCtD
Rescinnamine—SLC18A2—adrenal gland—hypothyroidism	0.0195	0.0542	CbGeAlD
Rescinnamine—SLC18A2—blood—hypothyroidism	0.0195	0.0542	CbGeAlD
Rescinnamine—SLC18A2—thyroid gland—hypothyroidism	0.0188	0.0523	CbGeAlD
Rescinnamine—ACE—heart—hypothyroidism	0.0178	0.0496	CbGeAlD
Rescinnamine—Angina pectoris—Levothyroxine—hypothyroidism	0.0169	0.0294	CcSEcCtD
Rescinnamine—Angina pectoris—Dextrothyroxine—hypothyroidism	0.0169	0.0294	CcSEcCtD
Rescinnamine—ACE—cardiovascular system—hypothyroidism	0.0168	0.0468	CbGeAlD
Rescinnamine—SLC18A2—testis—hypothyroidism	0.0161	0.0448	CbGeAlD
Rescinnamine—ACE—gonad—hypothyroidism	0.0153	0.0424	CbGeAlD
Rescinnamine—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.0152	0.0266	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.0152	0.0266	CcSEcCtD
Rescinnamine—SLC18A2—liver—hypothyroidism	0.0152	0.0424	CbGeAlD
Rescinnamine—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.0151	0.0264	CcSEcCtD
Rescinnamine—Myocardial infarction—Levothyroxine—hypothyroidism	0.0151	0.0264	CcSEcCtD
Rescinnamine—ACE—pituitary gland—hypothyroidism	0.0149	0.0414	CbGeAlD
Rescinnamine—SLC18A2—cerebellum—hypothyroidism	0.0149	0.0414	CbGeAlD
Rescinnamine—SLC18A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.0145	0.214	CbGpPWpGaD
Rescinnamine—ACE—adrenal gland—hypothyroidism	0.0133	0.037	CbGeAlD
Rescinnamine—ACE—blood—hypothyroidism	0.0133	0.037	CbGeAlD
Rescinnamine—ACE—thyroid gland—hypothyroidism	0.0128	0.0357	CbGeAlD
Rescinnamine—Angina pectoris—Liotrix—hypothyroidism	0.0124	0.0217	CcSEcCtD
Rescinnamine—ACE—female gonad—hypothyroidism	0.0124	0.0345	CbGeAlD
Rescinnamine—Bronchitis—Liotrix—hypothyroidism	0.0122	0.0214	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Liotrix—hypothyroidism	0.0112	0.0195	CcSEcCtD
Rescinnamine—Myocardial infarction—Liotrix—hypothyroidism	0.0111	0.0194	CcSEcCtD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.0111	0.164	CbGpPWpGaD
Rescinnamine—ACE—testis—hypothyroidism	0.011	0.0306	CbGeAlD
Rescinnamine—ACE—liver—hypothyroidism	0.0104	0.0289	CbGeAlD
Rescinnamine—Hypoaesthesia—Liotrix—hypothyroidism	0.0101	0.0177	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00897	0.0157	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00897	0.0157	CcSEcCtD
Rescinnamine—Insomnia—Levothyroxine—hypothyroidism	0.00891	0.0155	CcSEcCtD
Rescinnamine—Insomnia—Dextrothyroxine—hypothyroidism	0.00891	0.0155	CcSEcCtD
Rescinnamine—Dysgeusia—Liotrix—hypothyroidism	0.00869	0.0152	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00805	0.0141	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00805	0.0141	CcSEcCtD
Rescinnamine—Urticaria—Dextrothyroxine—hypothyroidism	0.00782	0.0137	CcSEcCtD
Rescinnamine—Urticaria—Levothyroxine—hypothyroidism	0.00782	0.0137	CcSEcCtD
Rescinnamine—Abdominal pain—Levothyroxine—hypothyroidism	0.00778	0.0136	CcSEcCtD
Rescinnamine—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00778	0.0136	CcSEcCtD
Rescinnamine—Hypertension—Liotrix—hypothyroidism	0.00766	0.0134	CcSEcCtD
Rescinnamine—Oedema—Liotrix—hypothyroidism	0.00724	0.0126	CcSEcCtD
Rescinnamine—Infection—Liotrix—hypothyroidism	0.0072	0.0126	CcSEcCtD
Rescinnamine—Pruritus—Levothyroxine—hypothyroidism	0.00697	0.0122	CcSEcCtD
Rescinnamine—Pruritus—Dextrothyroxine—hypothyroidism	0.00697	0.0122	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.0066	0.0115	CcSEcCtD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—CLTC—hypothyroidism	0.00657	0.0972	CbGpPWpGaD
Rescinnamine—Insomnia—Liotrix—hypothyroidism	0.00655	0.0114	CcSEcCtD
Rescinnamine—Paraesthesia—Liotrix—hypothyroidism	0.0065	0.0114	CcSEcCtD
Rescinnamine—Rash—Levothyroxine—hypothyroidism	0.00621	0.0108	CcSEcCtD
Rescinnamine—Rash—Dextrothyroxine—hypothyroidism	0.00621	0.0108	CcSEcCtD
Rescinnamine—Dermatitis—Dextrothyroxine—hypothyroidism	0.0062	0.0108	CcSEcCtD
Rescinnamine—Dermatitis—Levothyroxine—hypothyroidism	0.0062	0.0108	CcSEcCtD
Rescinnamine—Constipation—Liotrix—hypothyroidism	0.00619	0.0108	CcSEcCtD
Rescinnamine—Headache—Dextrothyroxine—hypothyroidism	0.00617	0.0108	CcSEcCtD
Rescinnamine—Headache—Levothyroxine—hypothyroidism	0.00617	0.0108	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Liotrix—hypothyroidism	0.00592	0.0103	CcSEcCtD
Rescinnamine—Nausea—Dextrothyroxine—hypothyroidism	0.00585	0.0102	CcSEcCtD
Rescinnamine—Nausea—Levothyroxine—hypothyroidism	0.00585	0.0102	CcSEcCtD
Rescinnamine—Urticaria—Liotrix—hypothyroidism	0.00575	0.01	CcSEcCtD
Rescinnamine—Abdominal pain—Liotrix—hypothyroidism	0.00573	0.00999	CcSEcCtD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00567	0.0838	CbGpPWpGaD
Rescinnamine—Hypersensitivity—Liotrix—hypothyroidism	0.00534	0.00931	CcSEcCtD
Rescinnamine—Pruritus—Liotrix—hypothyroidism	0.00512	0.00894	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—TSHB—hypothyroidism	0.00509	0.0753	CbGpPWpGaD
Rescinnamine—Dizziness—Liotrix—hypothyroidism	0.00479	0.00836	CcSEcCtD
Rescinnamine—Rash—Liotrix—hypothyroidism	0.00457	0.00797	CcSEcCtD
Rescinnamine—Dermatitis—Liotrix—hypothyroidism	0.00456	0.00796	CcSEcCtD
Rescinnamine—Headache—Liotrix—hypothyroidism	0.00454	0.00792	CcSEcCtD
Rescinnamine—Nausea—Liotrix—hypothyroidism	0.0043	0.00751	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00318	0.047	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00258	0.0381	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—SLC5A7—hypothyroidism	0.00244	0.036	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00214	0.0316	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00205	0.0303	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—POMC—hypothyroidism	0.00199	0.0295	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—IGF1—hypothyroidism	0.00192	0.0284	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—NEFL—hypothyroidism	0.00157	0.0232	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00131	0.0194	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00109	0.016	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00103	0.0152	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—TSHB—hypothyroidism	0.000962	0.0142	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000811	0.012	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000523	0.00774	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000412	0.00609	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—POMC—hypothyroidism	0.000377	0.00557	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—IGF1—hypothyroidism	0.000362	0.00536	CbGpPWpGaD
